US Patent 8343992 Synthesis of
Patent 8343992 was granted and assigned to Progenics Pharmaceuticals on January, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 26 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+201 characters)
Article
Patent abstract
This invention relates to stereoselective synthesis of R-MNTX and intermediates thereof, pharmaceutical preparations comprising R-MNTX or intermediates thereof and methods for their use.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Harold D. Doshan0
Julio Perez0
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08343992 Synthesis of US Patent 8343992 Synthesis of
Infobox
Patent Number
083439920
Patent Number
83439920
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
083439920
Date of Patent
January 1, 2013
0Patent Application Number
126920830
Date Filed
January 22, 2010
0Patent Primary Examiner
Edits on 15 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08343992 Synthesis of
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08343992
Date of patent
January 1, 2013
Patent application number
12692083
Date Filed
January 22, 2010
Patent primary examiner
Find more entities like US Patent 8343992 Synthesis of
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.